Filter Results:
(68)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Show Results For
- All HBS Web (499)
- Faculty Publications (186)
Sort by
- 01 Jan 2003
- News
Daniel L. Vasella, M.D.
aspirations, purpose, and values, so that they work together as an aligned team." Dan Vasella finds that the skills he called upon as a practicing physician are equally useful in running one of the world's largest pharmaceutical... View Details
- 01 Mar 2017
- News
How Deep Brain Stimulation Could Change Medicine
psychiatric patients. This targeted approach gives Bennet hope that Harmoni can benefit not only people suffering from movement disorders, but also a whole class of psychiatric patients. But working under Bennet and his collaborator, neurosurgeon Kendall Lee, a team of... View Details
Keywords: Janelle Nanos
- 01 Dec 2003
- News
The Next Big Thing
research and commercialization of biotechnology and biomedicine, the life sciences’ core activities? And what steps must be taken to maintain preeminence? In a keynote presentation at a September “Massachusetts Life Sciences Summit,” HBS... View Details
- 15 Apr 2014
- News
Bertarelli Foundation Gift Names Deans' Health & Life Sciences Challenge Prize
entrepreneur who has had a successful career in business, finance, yachting, and philanthropy. He is the former CEO of Serono SA (formerly known Ares-Serono), a family-controlled global pharmaceuticals and biotechnology leader whose roots... View Details
- 06 Mar 2018
- News
A Voice for Diversity and Impact at Scale
its Pharmaceutical and Medical Products Practice in Europe, the Middle East, and Africa. And as a member of the global board of directors, she has spearheaded flagship research linking diversity to... View Details
- 24 Sep 2020
- News
The Race for a Vaccine
NIH for clinical testing. The company had moved from concept to clinical-trial-ready in a record-breaking 42 days. Moderna is just one of scores of research teams worldwide currently shepherding vaccine candidates through development and... View Details
- 03 Nov 2016
- News
17 Ventures Join the Pagliuca Harvard Life Lab
Institute/HMS Nix – HBS, SEAS, Blavatnik Fellow PathoVax – HMS Piper Therapeutics – College, HBS Riparian Pharmaceuticals – College, SEAS Suono Bio – HMS UnNamed – HMS UrSure Inc. – HKS Vaxess Technologies, Inc. HBS, SEAS, HKS, HLS... View Details
- 01 Mar 2005
- News
Facing Ambiguity
research associates Erika Ferlins and Laura Feldman, students are assigned the parts of six managers or engineers who were involved in the Columbia mission. After logging into their password-protected role, students watch, read, and... View Details
- 14 May 2014
- News
(Re)moving the Needle
You wouldn't think that the lowly, annoying mosquito would have anything to teach researchers working on the cutting edge of drug delivery methodology, but you would be wrong. Have you ever noticed that you don't become aware of a... View Details
- 23 Aug 2020
- News
In the UK, She Leads the Search for a COVID Vaccine
told the Daily Mail. In fact, Bingham’s role—working with pharmaceutical firms, planning manufacturing facilities, and making investment decisions—ties in directly with her career experience. “As a venture capitalist, I have to write a... View Details
- 01 Sep 2010
- News
Fair Trade
pharmaceuticals and software, and far above the average of all industries. Many apparent paradoxes add to the puzzle posed by the industry. While rarely considered fundamentally “bad,” such as the trade in narcotics or tobacco, the beauty... View Details
- 01 Dec 1996
- News
New Releases
Technology Fountainheads by E. Raymond Corey (Harvard Business School Press) As corporate research and development costs rise, many firms choose to participate in R&D; consortia - collaborative ventures with academic institutions and... View Details
- 01 Mar 2016
- News
Off Script
according to one study—and the limited lifespan of patent rights. What can the pharmaceutical industry and government regulators do to improve conditions? We put your queries to Fred Hassan (MBA 1972), a managing director at Warburg... View Details
- 18 Sep 2014
- News
Room to grow: global expansion in the middle ground
global players with hundreds of millions, and sometimes billions, of dollars in sales. Their middle-ground strategies emerged from Israel’s small size, relative isolation, and cadre of executives accustomed to military maneuvering. Ofek, who conducted his View Details
- 01 Jun 2011
- News
The Best-Laid Plans
failed companies. When Potentia Pharmaceuticals won the contest in 2001 with Alec Machiels (MBA 2001) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug... View Details
- 20 Jul 2022
- News
Wired to be Inspired
Subscribe on iTunes Subscribe on Spotify More Skydeck episodes Professor Ranjay Gulati, whose research looks at how the most resilient companies approach growth and profitability, chaired the Advanced Management Program at HBS for many... View Details
- 24 Apr 2014
- News
Giving hope and inspiration to cancer patients around the globe
Every new day is a good day for Kathryn E. Giusti (MBA 1985) since that morning in 1996 when her oncologist told her to get her affairs in order because she had a rare blood cancer, with three years to live. Leveraging her past experience as a View Details
- 08 Jun 2021
- News
New Funding for Female Founders
a patient’s home. “A pharmaceutical company, for instance, may want to study how well patients on a particular medication are able to sleep. HumanFirst can scan the clinical-research landscape to identify studies in which View Details
- 01 Mar 2007
- News
In Brief
Q&A with Daniel Vasella. Initially regarded by critics as too inexperienced to lead a major pharmaceutical company, Daniel Vasella (PMD 57, 1989) has set a new standard for innovation as CEO of Novartis. The Winning Season. Last year, St.... View Details
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details